Cited by 299Diabetes Management and ResearchDiabetes Management and EducationDiabetes and associated disorders

Persistent Differences Among Centers Over 3 Years in Glycemic Control and Hypoglycemia in a Study of 3,805 Children and Adolescents With Type 1 Diabetes From the Hvidøre Study Group

Open access
Danne, Thomas, Mortensen, Henrik B., Hougaard, Philip, Lynggaard, Helle, Aanstoot, Henk-Jan, Chiarelli, Francesco, Daneman, Denis, Dorchy, Harry +16 more·2001·Diabetes Care

Abstract

OBJECTIVE—Twenty-one international pediatric diabetes centers from 17 countries investigated the effect of simple feedback about the grand mean HbA1c level of all centers and the average value of each center on changes in metabolic control, rate of severe hypoglycemia, and insulin therapy over a 3-year period. RESEARCH DESIGN AND METHODS—Clinical data collection and determination of HbA1c levels were conducted at a central location in 1995 (n = 2,780, age 0–18 years) and 1998 (n = 2,101, age 11–18 years). RESULTS—Striking differences in average HbA1c concentrations were found among centers; these differences remained after adjustment for the significant confounders of sex, age, and diabetes duration. They were apparent even in patients with short diabetes duration and remained stable 3 years later (mean adjusted HbA1c level: 8.62 ± 0.03 vs. 8.67 ± 0.04 [1995 vs. 1998, respectively]). Three centers had improved significantly, four centers had deteriorated significantly in their overall adjusted HbA1c levels, and 14 centers had not changed in glycemic control. During the observation period, there were increases in the adjusted insulin dose by 0.076 U/kg, the adjusted number of injections by 0.23 injections per day, and the adjusted BMI by 0.95 kg/m2. The 1995 versus 1998 difference in glycemic control for the seven centers could not be explained by prevailing insulin regimens or rates of hypoglycemia. CONCLUSIONS—This study reveals significant outcome differences among large international pediatric diabetes centers. Feedback and comparison of HbA1c levels led to an intensification of insulin therapy in most centers, but improved glycemic control in only a few.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diacare.24.8.1342

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The DCCT demonstrated that intensive glycemic control reduces the long-term vascular complications of hyperglycemia in type 1 diabetes.

    “The DCCT demonstrated that intensive glycemic control reduces the long-term vascular complications of hyperglycemia in T1D.”

    From Epidemiology of type 1 diabetes (2010) · cites this paper as [86]

  • Rates of hypoglycemia were higher in adolescents than in adults.

    “Despite this, rates of hypoglycemia were higher in adolescents than in adults86.”

    From Epidemiology of type 1 diabetes (2010) · cites this paper as [86]

  • Intensive glycemic control improves vascular outcomes in type 1 diabetes.

    “Of note, these data from Hvidore and SEARCH are post-DCCT in which it has been shown conclusively that intensive glycemic control improves vascular outcomes in T1D.”

    From Epidemiology of type 1 diabetes (2010) · cites this paper as [86]

  • In the DCCT, mean A1c for adolescents compared with adults was 1-2% higher in both the intensive and conventionally treated arms.

    “However, even in the Diabetes Control and Complications Trial (DCCT) the mean A1c for adolescents as compared to adults was 1–2% higher in both the intensive and conventionally treated arms.”

    From Epidemiology of type 1 diabetes (2010) · cites this paper as [86]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Danne, T., Mortensen, H. B., Hougaard, P., Lynggaard, H., Aanstoot, H.-J., Chiarelli, F., Daneman, D., Dorchy, H., Garandeau, P., Greene, S. A., Hoey, H., Holl, R. W., Kaprio, E. A., Kocova, M., Martul, P., Matsuura, N., Robertson, K. J., Schoenle, E. J., Søvik, O., Swift, P. G. F., Tsou, R. M., Vanelli, M., Åman, J., & for the Hvidøre Study Group on Childhood Diabetes
Affiliations
  • Humboldt-Universität zu Berlin (DE)
  • Glostrup Hospital (DK)
  • Novo Nordisk (Denmark) (DK)
  • Erasmus MC - Sophia Children’s Hospital (NL)
  • University of Chieti-Pescara (IT)
  • University of Toronto (CA)
  • Queen Fabiola Children's University Hospital (BE)
  • Institut St. Pierre, Montpellier, France
  • Ninewells Hospital (GB)
  • Tallaght University Hospital (IE)
  • Universität Ulm (DE)
  • Peijas Hospital (FI)
  • University Pediatric Clinic, Skopje, Republic of Macedonia
  • Hospital de Cruces (ES)
  • Kitasato University (JP)
  • Royal Hospital for Children (GB)
  • University Children's Hospital Zurich (CH)
  • Department of Pediatrics, Haukeland Hospital, Bergen, Norway
  • Leicester Royal Infirmary (GB)
  • Hospital de São João (PT)
  • University of Parma (IT)
  • Örebro Regional Hospital, Örebro, Sweden
Venue
Diabetes Care
Published
2001-08-01
Volume
24
Issue
8
Pages
1342-1347
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2166158593
Cited by
299
References
19
Citations by year
2025: 2 · 2023: 2 · 2022: 4 · 2021: 5 · 2020: 2 · 2019: 6 · 2018: 5 · 2017: 10 · 2016: 12 · 2015: 9 · 2014: 19 · 2013: 17 · 2012: 27
FWCI
6.66
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
  • Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
Funders
Novo Nordisk
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords
type 1 diabetes, pediatric diabetes, glycemic control, HbA1c, hypoglycemia, insulin therapy, performance feedback
MeSH terms
Adolescent, Blood Glucose, Child, Cross-Sectional Studies, Diabetes Mellitus, Type 1, Europe, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Insulin, Japan, Male, North America, Reproducibility of Results, Biomarkers, Incidence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review